FLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fluor Corp (FLR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are positive catalysts such as institutional interest and potential growth in the nuclear sector, the company's weak financial performance, declining revenue, and negative earnings make it a risky investment currently. The technical indicators also suggest a bearish trend, and there are no strong proprietary trading signals to justify immediate action.
The MACD histogram is negative and expanding (-0.644), indicating bearish momentum. RSI is at 24.504, suggesting the stock is approaching oversold territory but not yet signaling a reversal. Moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 46.892), with resistance levels significantly higher (R1: 53.615). Overall, the technical indicators suggest a bearish trend.
Starboard Value LP acquired a significant stake in Fluor, indicating institutional confidence.
The IAEA's prediction of increased global nuclear capacity and NuScale's regulatory approvals position Fluor for potential growth in the nuclear sector.
Recent project wins, such as the Donlin Gold Project and FBS Global's construction pipeline, enhance Fluor's backlog and competitive position.
Weak Q4 2025 financial performance, with revenue down 1.97% YoY, net income down 184.43% YoY, and EPS down 191.74% YoY.
Gross margin dropped significantly to 3.18%, down 34.84% YoY, reflecting declining profitability.
The stock's price has declined 4.09% in the regular market, with bearish technical indicators.
No recent congress trading data or significant insider/hedge fund activity to provide additional confidence.
Fluor's Q4 2025 financials show a significant decline in performance. Revenue dropped by 1.97% YoY to $4.176 billion. Net income plummeted to -$1.573 billion, a 184.43% decline YoY, while EPS fell to -9.77, down 191.74%. Gross margin also dropped significantly to 3.18%, indicating weaker profitability.
Analysts are generally positive on Fluor, with multiple firms raising price targets recently. Citi raised its target to $61, UBS to $57, and Truist to $59, all maintaining Buy ratings. However, Baird remains Neutral with a price target of $48, citing muted earnings power. Analysts see potential in Fluor's backlog and new bookings but acknowledge challenges in the near term.
